Share Price:

APNASPENAspen Pharmacare Hldgs158730 (0.00%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Our Stories

Our Stories

From innovation to immunisation: Aspen adds Africa’s voice to global vaccine dialogue in Beijing

Aspen contributed an important African perspective to the 27th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN), which took place in Beijing, China, from 22 to 24 September 2026. Representing Aspen and the Southern African region, our Group Senior Executive: Strategic Trade, Stavros Nicolaou participated in his capacity as an elected member of the DCVMN Board of Directors.

Read More
Our Stories

Lorraine Hill joins industry leaders in conversation on gender, leadership and the future of manufacturing

Our Group Chief Operations Officer, Lorraine Hill, recently joined a diverse panel of industry leaders at the Toyota Wessels Institute for Manufacturing Studies’ breakfast seminar, in Durban. Held during South Africa’s Women’s Month, under the theme Gender, Generation and Leadership in the Manufacturing Sector, the session created an important platform for reflection on the progress made in advancing gender equity, the challenges that remain, and the leadership required to build a more inclusive and future-ready manufacturing sector.

Read More
Our Stories

Aspen champions local manufacturing at the 2026 Manufacturing Indaba

In July, our Group Senior Executive: Strategic Trade, Stavros Nicolaou, represented Aspen at the 2026 Manufacturing Indaba, one of Africa’s leading platforms for advancing industrial growth, localisation and manufacturing-led economic development. This year, there was a particular focus on establishing domestic and regional pharmaceutical value chains for export led growth into the African continent in line with the African Union’s ambition to produce 60% of Africa’s pharmaceutical requirements in Africa by 2040.

Read More

Media Enquiries

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Share on social

Follow on social

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: